Tower Research Capital LLC (Trc) Windtree Therapeutics Inc Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.16 - $281.7 $84 - $148,174	-526 Reduced 2.76%	18,564 $3,000
Q3 2022 Nov 10, 2022	SELL	$0.3 - $306.0 $2,833 - $2.89 Million	-9,444 Reduced 33.1%	19,090 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.38 - $1.14 $9,291 - $27,875	24,452 Added 599.02%	28,534 $12,000
Q1 2022 May 12, 2022	BUY	$0.94 - $1.6 $3,393 - $5,776	3,610 Added 764.83%	4,082 $5,000
Q4 2021 Feb 14, 2022	BUY	$1.4 - $2.31 $660 - $1,090	472 New	472 $1,000
Q3 2021 Nov 15, 2021	SELL	$1.66 - $2.27 $44,805 - $61,269	-26,991 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.68 - $2.79 $45,344 - $75,304	26,991 New	26,991 $62,000
Q1 2021 May 17, 2021	SELL	$2.14 - $6.18 $7,669 - $22,149	-3,584 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.98 - $7.47 $17,848 - $26,772	3,584 New	3,584 $19,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $22.1M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.